These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 33139858)

  • 1. ADARs, RNA editing and more in hematological malignancies.
    Teoh PJ; Koh MY; Chng WJ
    Leukemia; 2021 Feb; 35(2):346-359. PubMed ID: 33139858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms and implications of ADAR-mediated RNA editing in cancer.
    Wang C; Zou J; Ma X; Wang E; Peng G
    Cancer Lett; 2017 Dec; 411():27-34. PubMed ID: 28974449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. To protect and modify double-stranded RNA - the critical roles of ADARs in development, immunity and oncogenesis.
    Erdmann EA; Mahapatra A; Mukherjee P; Yang B; Hundley HA
    Crit Rev Biochem Mol Biol; 2021 Feb; 56(1):54-87. PubMed ID: 33356612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current strategies for Site-Directed RNA Editing using ADARs.
    Montiel-Gonzalez MF; Diaz Quiroz JF; Rosenthal JJC
    Methods; 2019 Mar; 156():16-24. PubMed ID: 30502398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An I for an A: Dynamic Regulation of Adenosine Deamination-Mediated RNA Editing.
    Vesely C; Jantsch MF
    Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The RNA editing enzymes ADARs: mechanism of action and human disease.
    Tomaselli S; Locatelli F; Gallo A
    Cell Tissue Res; 2014 Jun; 356(3):527-32. PubMed ID: 24770896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. irCLASH reveals RNA substrates recognized by human ADARs.
    Song Y; Yang W; Fu Q; Wu L; Zhao X; Zhang Y; Zhang R
    Nat Struct Mol Biol; 2020 Apr; 27(4):351-362. PubMed ID: 32203492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods for recruiting endogenous and exogenous ADAR enzymes for site-specific RNA editing.
    Xiang Y; Katrekar D; Mali P
    Methods; 2022 Sep; 205():158-166. PubMed ID: 35779766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An RNA editing/dsRNA binding-independent gene regulatory mechanism of ADARs and its clinical implication in cancer.
    Qi L; Song Y; Chan THM; Yang H; Lin CH; Tay DJT; Hong H; Tang SJ; Tan KT; Huang XX; Lin JS; Ng VHE; Maury JJP; Tenen DG; Chen L
    Nucleic Acids Res; 2017 Oct; 45(18):10436-10451. PubMed ID: 28985428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine deaminases acting on RNA (ADARs): RNA-editing enzymes.
    Keegan LP; Leroy A; Sproul D; O'Connell MA
    Genome Biol; 2004; 5(2):209. PubMed ID: 14759252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA editing by mammalian ADARs.
    Hogg M; Paro S; Keegan LP; O'Connell MA
    Adv Genet; 2011; 73():87-120. PubMed ID: 21310295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How do ADARs bind RNA? New protein-RNA structures illuminate substrate recognition by the RNA editing ADARs.
    Thomas JM; Beal PA
    Bioessays; 2017 Apr; 39(4):. PubMed ID: 28217931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic.
    Ganem NS; Ben-Asher N; Lamm AT
    Drug Resist Updat; 2017 May; 32():16-22. PubMed ID: 29145975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of exceptionally potent adenosine deaminases RNA editors from high body temperature organisms.
    Avram-Shperling A; Kopel E; Twersky I; Gabay O; Ben-David A; Karako-Lampert S; Rosenthal JJC; Levanon EY; Eisenberg E; Ben-Aroya S
    PLoS Genet; 2023 Mar; 19(3):e1010661. PubMed ID: 36877730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine Deaminases Acting on RNA (ADARs) and Viral Infections.
    Pfaller CK; George CX; Samuel CE
    Annu Rev Virol; 2021 Sep; 8(1):239-264. PubMed ID: 33882257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine Deaminases That Act on RNA (ADARs).
    Wang Y; Zheng Y; Beal PA
    Enzymes; 2017; 41():215-268. PubMed ID: 28601223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editing independent effects of ADARs on the miRNA/siRNA pathways.
    Heale BS; Keegan LP; McGurk L; Michlewski G; Brindle J; Stanton CM; Caceres JF; O'Connell MA
    EMBO J; 2009 Oct; 28(20):3145-56. PubMed ID: 19713932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bidirectional regulation of adenosine-to-inosine (A-to-I) RNA editing by DEAH box helicase 9 (DHX9) in cancer.
    Hong H; An O; Chan THM; Ng VHE; Kwok HS; Lin JS; Qi L; Han J; Tay DJT; Tang SJ; Yang H; Song Y; Bellido Molias F; Tenen DG; Chen L
    Nucleic Acids Res; 2018 Sep; 46(15):7953-7969. PubMed ID: 29796672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymmetric dimerization of adenosine deaminase acting on RNA facilitates substrate recognition.
    Thuy-Boun AS; Thomas JM; Grajo HL; Palumbo CM; Park S; Nguyen LT; Fisher AJ; Beal PA
    Nucleic Acids Res; 2020 Aug; 48(14):7958-7972. PubMed ID: 32597966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteome diversification by adenosine to inosine RNA editing.
    Pullirsch D; Jantsch MF
    RNA Biol; 2010; 7(2):205-12. PubMed ID: 20200492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.